Knut Stieger

[The treatment of inherited dystrophies and neovascular disorders of the retina by rAAV-mediated gene therapy].

tgAAG76, an adeno-associated virus delivered gene therapy for the potential treatment of vision loss caused by RPE65 gene abnormalities.

Gene therapy for vision loss -- recent developments.

The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies.

Quantification of the vascular endothelial growth factor with a bioluminescence resonance energy transfer (BRET) based single molecule biosensor.

In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies.

Detection of the Vascular Endothelial Growth Factor with a Novel Bioluminescence Resonance Energy Transfer Pair Using a Two-Component System.

Optimizing the DNA Donor Template for Homology-Directed Repair of Double-Strand Breaks.

Development of a Reporter System to Explore MMEJ in the Context of Replacing Large Genomic Fragments.

Toward genome editing in X-linked RP-development of a mouse model with specific treatment relevant features.

Novel Needle for Intravitreal Drug Delivery: Comparative Study of Needle Tip Aspirates, Injection Stream and Penetration Forces.

Combination of Inverted ILM Flap Technique and Subretinal Fluid Application Technique for Treatment of Chronic, Persistent and Large Macular Holes.

Retinal tissue develops an inflammatory reaction to tobacco smoke and electronic cigarette vapor in mice.

Subretinal Implantation of Human Primary RPE Cells Cultured on Nanofibrous Membranes in Minipigs.